Regulatory T cell enhancement in adults with cystic fibrosis receiving Elexacaftor/Tezacaftor/Ivacaftor therapy.

Front Immunol · 2023 · PMC9978140 · PMID 36875141

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

did not reach statistical significancep=0.10so close (0.05 < p ≤ 0.1)

8.7% of T helper cells), but the between-group difference did not reach statistical significance (p=0.10; Figure 3 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.